Drug Trial Radar · NCT05764733
Bone, Exercise, Alendronate, and Caloric Restriction
Last checked: Nov 20, 2026Latest source record: Jun 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
900
Planned (sponsor's estimate)
Start
Jun 8, 2023
Primary completion
Jan 2028
Study completion Jan 2028
Sponsor
- Lead sponsor
- Wake Forest University Health SciencesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute on Aging (NIA)
- First posted
- Mar 13, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research is to identify strategies that minimize bone loss that occurs when older adults lose weight. Participation in this research will involve up to nine assessment visits and last up to two years.
Conditions
- Bone Loss
Interventions
BisphosphonateDrug
Medicine used to treat bone problems, called osteopenia or osteoporosis.
Resistance Training/Bone-Loading ExerciseBehavioral
Exercise in small groups three days per week under the supervision of exercise physiologists. Heart rate and blood pressure will be measured before and after each session and participants will warm-up by walking or cycling for five minutes at a slow pace. All RT exercises will be conducted on machines which accommodate different body sizes and allow small increments in resistance, both important considerations for low functioning older adults with obesity.
PlaceboOther
Capsules identical to the active alendronate capsules without any active ingredients with the same dosing and follow up as BIS treatment group.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in total hip areal bone mineral density (aBMD)Time frame: from baseline through month 12
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
University of Colorado Anschutz Medical Campus
Aurora, Colorado · Recruiting
Atrium Health Wake Forest Baptist Medical Center
Winston-Salem, North Carolina · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.